Platelet Aggregation is not Enhanced in Patients with Prediabetes

  • Teoman Dogru
  • Halil Genc
  • Ilker Tasci
  • Alper Sonmez
  • Gokhan Erdem
  • Ali U. Ural
  • Ferit Avcu
  • Serap Savasci
  • Selim Kilic
  • Selahattin Erikci

Abstract

Prediabetes [impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG)] is a major risk factor for T2DM as well as for cardiovascular disease and mortality. In the present study, the platelet aggregation and fibrinogen levels were investigated in prediabetic subjects who had no confounding factors such as hypertension, obesity or dyslipidemia. Thirty-nine subjects with prediabetes (24 IFG and 15 IGT) and age, sex and BMI matched 36 healthy controls were enrolled. Platelet aggregation, fibrinogen and hsCRP levels, HOMA-IR and HOMA-β indexes were determined. Platelet aggregation induced by collagen, epinephrine or ADP was not different (p=0.93, p=0.90 and p=0.29, respectively) between two groups, whereas fibrinogen levels were significantly higher (p=0.006) in the prediabetics when compared to controls. hsCRP levels, HOMA-IR and HOMA-β indexes in the two groups were not different. The power of the study was calculated according to the results and established as 0.97 for collagen, 0.95 for epinephrine and 0.83 for ADP. Despite the high plasma fibrinogen levels, the platelet aggregation in prediabetics was not different when compared to healthy controls. These data suggest that platelet aggregation may not be involved in the mechanism of prothrombotic state in prediabetic state.

Downloads

Download data is not yet available.
Published
2009-07-12
How to Cite
Dogru T., Genc H., Tasci I., Sonmez A., Erdem G., Ural A. U., Avcu F., Savasci S., Kilic S., & Erikci S. (2009). Platelet Aggregation is not Enhanced in Patients with Prediabetes. Upsala Journal of Medical Sciences, 112(3), 338–346. https://doi.org/10.3109/2000-1967-206
Section
Original Articles

Most read articles by the same author(s)